Tapewire

Nasdaq · USD

AHCO

AdaptHealth Corp.

Export transactions ↓
Tapewire entity
5183
SEC CIK
0001725255
Parsed reports
346

Last 12 months

Inside the activity.

16 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202501
Jan 202600
Feb 202620
Mar 2026100
Apr 202600
May 202600
Jun 202601
Jul 202601
Aug 202640
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 09, 2026 Filed Sep 11, 2026 20:11 UTC
CURRIE HARRISS TCHIEF FINANCIAL OFFICER
GrantCommon Stock 141,372 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-107061 · tm2625233-2_4seq1.xml · nonDerivative · entry 1

CURRIE HARRISS T · CIK 0001238407 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,372

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
August 07, 2026 Filed Aug 11, 2026 00:02 UTC
WOLF DALE BDirector
PurchaseCommon Stock 20,000 $5.86 $117,200.00
Disclosure

SEC source: 0001104659-26-093575 · tm2622716-1_4seq1.xml · nonDerivative · entry 2

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 34,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.83 to $5.885, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

F2 · ownership.nature: Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST.

Read SEC document
August 06, 2026 Filed Aug 11, 2026 00:02 UTC
WOLF DALE BDirector
PurchaseCommon Stock 20,000 $6.37 $127,400.00
Disclosure

SEC source: 0001104659-26-093575 · tm2622716-1_4seq1.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,234

Read SEC document
August 06, 2026 Filed Aug 11, 2026 00:03 UTC PurchaseCommon Stock 23,500 $6.38 $149,930.00
Disclosure

SEC source: 0001104659-26-093576 · tm2622716-2_4seq1.xml · nonDerivative · entry 1

SAMET KENNETH A · CIK 0001359252 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,569

Read SEC document
August 06, 2026 Filed Aug 14, 2026 20:01 UTC Amendment
WOLF DALE BDirector
PurchaseCommon Stock 20,000 $6.30 $126,000.00
Disclosure

SEC source: 0001104659-26-097053 · tm2623267-1_4aseq1.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,234

F1 · price: The Form 4 originally filed on August 10, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.335, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

Read SEC document
July 01, 2026 Filed Jul 6, 2026 20:01 UTC
Schuster III Russell E.Chief Commercial Officer
SaleCommon Stock 11,275 $10.44 $117,711.00
Disclosure

SEC source: 0001104659-26-080730 · tm2619811-1_4seq1.xml · nonDerivative · entry 1

Schuster III Russell E. · CIK 0002048040 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,263

F1 · kind: The sale reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2026.

Read SEC document
June 24, 2026 Filed Jun 26, 2026 20:20 UTC GrantCommon Stock 18,999 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-078285 · tm2619030-9_4seq1.xml · nonDerivative · entry 1

Williams David Solomon III · CIK 0001820444 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,044

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
June 24, 2026 Filed Jun 26, 2026 20:14 UTC GrantCommon Stock 18,999 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-078268 · tm2619030-7_4seq1.xml · nonDerivative · entry 1

Connors Terence J · CIK 0001689279 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,262

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
June 24, 2026 Filed Jun 26, 2026 20:17 UTC GrantCommon Stock 18,999 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-078281 · tm2619030-8_4seq1.xml · nonDerivative · entry 1

Weaver Susan T · CIK 0001687804 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,345

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
June 24, 2026 Filed Jun 26, 2026 20:10 UTC GrantCommon Stock 18,999 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-078262 · tm2619030-5_4seq1.xml · nonDerivative · entry 1

Coppens Bradley J · CIK 0001487729 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,345

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
June 24, 2026 Filed Jun 26, 2026 20:12 UTC GrantCommon Stock 18,999 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-078264 · tm2619030-6_4seq1.xml · nonDerivative · entry 1

BELINFANTI GREGORY · CIK 0001471787 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,269

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
June 24, 2026 Filed Jun 26, 2026 20:04 UTC
WOLF DALE BDirector
GrantCommon Stock 18,999 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-078240 · tm2619030d3_4seq1.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,234

F1 · price: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
June 24, 2026 Filed Jun 26, 2026 20:04 UTC GrantCommon Stock 6,070 $9.89 $60,032.30
Disclosure

SEC source: 0001104659-26-078238 · tm2619030-2_4seq1.xml · nonDerivative · entry 2

SAMET KENNETH A · CIK 0001359252 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,069

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
June 24, 2026 Filed Jun 26, 2026 20:04 UTC GrantCommon Stock 18,999 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-078238 · tm2619030-2_4seq1.xml · nonDerivative · entry 1

SAMET KENNETH A · CIK 0001359252 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,999

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
June 24, 2026 Filed Jun 26, 2026 20:08 UTC GrantCommon Stock 18,999 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-078257 · tm2619030-4_4seq1.xml · nonDerivative · entry 1

Lundberg Theodore B. · CIK 0001628260 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 892,495

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 22:43 UTC
Schuster III Russell E.Chief Commercial Officer
SaleCommon Stock 11,275 $10.06 $113,426.50
Disclosure

SEC source: 0001104659-26-070230 · tm2616845-1_4seq1.xml · nonDerivative · entry 1

Schuster III Russell E. · CIK 0002048040 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 136,538

F1 · kind: The sale reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2026.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:15 UTC
McFadden Daniel EdwardChief Operating Officer
GrantCommon Stock 20,134 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-068272 · tm2616037-1_4seq1.xml · nonDerivative · entry 1

McFadden Daniel Edward · CIK 0002074058 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,376

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
March 20, 2026 Filed Mar 23, 2026 22:25 UTC PurchaseCommon Stock 447,100 $9.91 $4,431,699.91
Disclosure

SEC source: 0001193125-26-120145 · ownership.xml · nonDerivative · entry 2

CASHIN RICHARD M JR · CIK 0001172898 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 16,312,698

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.81 to $9.95, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These securities are held directly by OEP AHCO Investment Holdings, LLC ("Investor"). Investor is owned by One Equity Partners VII, L.P., a Cayman Islands exempted limited partnership ("OEP VII LP"), One Equity Partners VII-A, L.P., a Cayman Islands exempted limited partnership ("OEP VII-A LP"), One Equity Partners VII-B, L.P., a Delaware limited partnership ("OEP VII-B LP"), OEP VII Project A Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A LP") and OEP VII Project A-I Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A-I LP" and, together with OEP VII LP, OEP VII-A LP, OEP VII-B LP and OEP VII Project A LP, the "Parallel Funds"). The general partner of each of the Parallel Funds is OEP VII General Partner, L.P., a Cayman Islands exempted limited partnership ("OEP VII GP"), and the general partner of OEP VII GP is OEP VII GP, L.L.C., a Cayman Islands limited liability company ("OEP VII GP LLC").

F3 · ownership.nature: (Continued from Footnote 2) The six member investment committee of OEP VII GP acts by majority vote, which majority must include Richard Cashin. Accordingly, Richard Cashin may be deemed to have voting and investment discretion, and beneficial ownership, of the reported securities. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.

Read SEC document
March 20, 2026 Filed Mar 30, 2026 23:49 UTC Amendment PurchaseCommon Stock 447,100 $9.91 $4,431,699.91
Disclosure

SEC source: 0001193125-26-132703 · ownership.xml · nonDerivative · entry 2

OEP VII GP, L.L.C. · CIK 0001817118 · 10% owner

OEP AHCO Investment Holdings, LLC · CIK 0001817112 · 10% owner

ONE EQUITY PARTNERS VII, L.P. · CIK 0001733523 · 10% owner

ONE EQUITY PARTNERS VII-A, L.P. · CIK 0001733525 · 10% owner

ONE EQUITY PARTNERS VII-B, L.P. · CIK 0001733528 · 10% owner

OEP VII Project A Co-Investment Partners, L.P. · CIK 0001817120 · 10% owner

OEP VII PROJECT A-I CO-INVESTMENT PARTNERS, L.P. · CIK 0001821208 · 10% owner

OEP VII General Partner, L.P. · CIK 0001817115 · 10% owner

CASHIN RICHARD M JR · CIK 0001172898 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See

Disclosed balance after: 16,312,698

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.81 to $9.95, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These securities are held directly by OEP AHCO Investment Holdings, LLC ("Investor"). Investor is owned by One Equity Partners VII, L.P., a Cayman Islands exempted limited partnership ("OEP VII LP"), One Equity Partners VII-A, L.P., a Cayman Islands exempted limited partnership ("OEP VII-A LP"), One Equity Partners VII-B, L.P., a Delaware limited partnership ("OEP VII-B LP"), OEP VII Project A Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A LP") and OEP VII Project A-I Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A-I LP" and, together with OEP VII LP, OEP VII-A LP, OEP VII-B LP and OEP VII Project A LP, the "Parallel Funds"). The general partner of each of the Parallel Funds is OEP VII General Partner, L.P., a Cayman Islands exempted limited partnership ("OEP VII GP"), and the general partner of OEP VII GP is OEP VII GP, L.L.C., a Cayman Islands limited liability company ("OEP VII GP LLC").

F3 · ownership.nature: (Continued from Footnote 2) The six member investment committee of OEP VII GP acts by majority vote, which majority must include Richard Cashin. Accordingly, Richard Cashin may be deemed to have voting and investment discretion, and beneficial ownership, of the reported securities. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.

Read SEC document
March 19, 2026 Filed Mar 23, 2026 22:25 UTC PurchaseCommon Stock 727 $9.94 $7,227.62
Disclosure

SEC source: 0001193125-26-120145 · ownership.xml · nonDerivative · entry 1

CASHIN RICHARD M JR · CIK 0001172898 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 15,865,598

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.94 to $9.95, inclusive. The reporting persons undertake to provide to AdaptHealth Corp., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These securities are held directly by OEP AHCO Investment Holdings, LLC ("Investor"). Investor is owned by One Equity Partners VII, L.P., a Cayman Islands exempted limited partnership ("OEP VII LP"), One Equity Partners VII-A, L.P., a Cayman Islands exempted limited partnership ("OEP VII-A LP"), One Equity Partners VII-B, L.P., a Delaware limited partnership ("OEP VII-B LP"), OEP VII Project A Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A LP") and OEP VII Project A-I Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A-I LP" and, together with OEP VII LP, OEP VII-A LP, OEP VII-B LP and OEP VII Project A LP, the "Parallel Funds"). The general partner of each of the Parallel Funds is OEP VII General Partner, L.P., a Cayman Islands exempted limited partnership ("OEP VII GP"), and the general partner of OEP VII GP is OEP VII GP, L.L.C., a Cayman Islands limited liability company ("OEP VII GP LLC").

F3 · ownership.nature: (Continued from Footnote 2) The six member investment committee of OEP VII GP acts by majority vote, which majority must include Richard Cashin. Accordingly, Richard Cashin may be deemed to have voting and investment discretion, and beneficial ownership, of the reported securities. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.

Read SEC document
March 19, 2026 Filed Mar 30, 2026 23:49 UTC Amendment PurchaseCommon Stock 727 $9.94 $7,227.62
Disclosure

SEC source: 0001193125-26-132703 · ownership.xml · nonDerivative · entry 1

OEP VII GP, L.L.C. · CIK 0001817118 · 10% owner

OEP AHCO Investment Holdings, LLC · CIK 0001817112 · 10% owner

ONE EQUITY PARTNERS VII, L.P. · CIK 0001733523 · 10% owner

ONE EQUITY PARTNERS VII-A, L.P. · CIK 0001733525 · 10% owner

ONE EQUITY PARTNERS VII-B, L.P. · CIK 0001733528 · 10% owner

OEP VII Project A Co-Investment Partners, L.P. · CIK 0001817120 · 10% owner

OEP VII PROJECT A-I CO-INVESTMENT PARTNERS, L.P. · CIK 0001821208 · 10% owner

OEP VII General Partner, L.P. · CIK 0001817115 · 10% owner

CASHIN RICHARD M JR · CIK 0001172898 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See

Disclosed balance after: 15,865,598

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.94 to $9.95, inclusive. The reporting persons undertake to provide to AdaptHealth Corp., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These securities are held directly by OEP AHCO Investment Holdings, LLC ("Investor"). Investor is owned by One Equity Partners VII, L.P., a Cayman Islands exempted limited partnership ("OEP VII LP"), One Equity Partners VII-A, L.P., a Cayman Islands exempted limited partnership ("OEP VII-A LP"), One Equity Partners VII-B, L.P., a Delaware limited partnership ("OEP VII-B LP"), OEP VII Project A Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A LP") and OEP VII Project A-I Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A-I LP" and, together with OEP VII LP, OEP VII-A LP, OEP VII-B LP and OEP VII Project A LP, the "Parallel Funds"). The general partner of each of the Parallel Funds is OEP VII General Partner, L.P., a Cayman Islands exempted limited partnership ("OEP VII GP"), and the general partner of OEP VII GP is OEP VII GP, L.L.C., a Cayman Islands limited liability company ("OEP VII GP LLC").

F3 · ownership.nature: (Continued from Footnote 2) The six member investment committee of OEP VII GP acts by majority vote, which majority must include Richard Cashin. Accordingly, Richard Cashin may be deemed to have voting and investment discretion, and beneficial ownership, of the reported securities. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 20:04 UTC
Prast Albert A.Chief Technology Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 89,451 $0.00 Strike: $4.38 $0.00
Disclosure

SEC source: 0001104659-26-028442 · tm268919-1_4seq1.xml · derivative · entry 3

Prast Albert A. · CIK 0001628262 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 89,451 shares

Expires 2026-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 20:04 UTC
Prast Albert A.Chief Technology Officer
Tax withholdingCommon Stock 58,203 $10.33 $601,236.99
Disclosure

SEC source: 0001104659-26-028442 · tm268919-1_4seq1.xml · nonDerivative · entry 2

Prast Albert A. · CIK 0001628262 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 474,155

Read SEC document
March 13, 2026 Filed Mar 16, 2026 20:04 UTC
Prast Albert A.Chief Technology Officer
Exercise / conversionCommon Stock 89,451 $4.38 $391,795.38
Disclosure

SEC source: 0001104659-26-028442 · tm268919-1_4seq1.xml · nonDerivative · entry 1

Prast Albert A. · CIK 0001628262 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 532,358

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 13, 2026 Filed Apr 28, 2026 23:32 UTC Amendment
Prast Albert A.Chief Technology Officer
Tax withholdingCommon Stock 58,203 $10.33 $601,236.99
Disclosure

SEC source: 0001104659-26-050577 · tm2612876-1_4aseq1.xml · nonDerivative · entry 1

Prast Albert A. · CIK 0001628262 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 338,712

F1 · date: This line item is re-reported solely to allow the filing of this amendment. The Form 4 filed for the reporting person on February 4, 2025 and subsequent Forms 4 filed on February 3, 2026 and March 16, 2026 inadvertently overstated the number of common stock owned by the reporting person by 135,443 shares. This amendment sets forth the number of shares of Common Stock beneficially owned by the reporting person following the transactions reported in the Form 4 hereby being amended.

F1 · kind: This line item is re-reported solely to allow the filing of this amendment. The Form 4 filed for the reporting person on February 4, 2025 and subsequent Forms 4 filed on February 3, 2026 and March 16, 2026 inadvertently overstated the number of common stock owned by the reporting person by 135,443 shares. This amendment sets forth the number of shares of Common Stock beneficially owned by the reporting person following the transactions reported in the Form 4 hereby being amended.

F1 · shares: This line item is re-reported solely to allow the filing of this amendment. The Form 4 filed for the reporting person on February 4, 2025 and subsequent Forms 4 filed on February 3, 2026 and March 16, 2026 inadvertently overstated the number of common stock owned by the reporting person by 135,443 shares. This amendment sets forth the number of shares of Common Stock beneficially owned by the reporting person following the transactions reported in the Form 4 hereby being amended.

F1 · price: This line item is re-reported solely to allow the filing of this amendment. The Form 4 filed for the reporting person on February 4, 2025 and subsequent Forms 4 filed on February 3, 2026 and March 16, 2026 inadvertently overstated the number of common stock owned by the reporting person by 135,443 shares. This amendment sets forth the number of shares of Common Stock beneficially owned by the reporting person following the transactions reported in the Form 4 hereby being amended.

F1 · balance_after: This line item is re-reported solely to allow the filing of this amendment. The Form 4 filed for the reporting person on February 4, 2025 and subsequent Forms 4 filed on February 3, 2026 and March 16, 2026 inadvertently overstated the number of common stock owned by the reporting person by 135,443 shares. This amendment sets forth the number of shares of Common Stock beneficially owned by the reporting person following the transactions reported in the Form 4 hereby being amended.

Read SEC document
March 12, 2026 Filed Mar 13, 2026 01:11 UTC PurchaseCommon Stock 689,336 $9.73 $6,707,170.35
Disclosure

SEC source: 0001193125-26-104760 · ownership.xml · nonDerivative · entry 3

CASHIN RICHARD M JR · CIK 0001172898 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 15,864,871

F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.55 to $9.75, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These securities are held directly by OEP AHCO Investment Holdings, VI LLC ("Investor"). Investor is owned by One Equity Partners VII, L.P., a Cayman Islands exempted limited partnership ("OEP VII LP"), One Equity Partners VII-A, L.P., a Cayman Islands exempted limited partnership ("OEP VII-A LP"), One Equity Partners VII-B, L.P., a Delaware limited partnership ("OEP VII-B LP"), OEP VII Project A Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A LP") and OEP VII Project A-I Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A-I LP" and, together with OEP VII LP, OEP VII-A LP, OEP VII-B LP and OEP VII Project A LP, the "Parallel Funds"). The general partner of each of the Parallel Funds is OEP VII General Partner, L.P., a Cayman Islands exempted limited partnership ("OEP VII GP"), and the general partner of OEP VII GP is OEP VII GP, L.L.C., a Cayman Islands limited liability company ("OEP VII GP LLC").

F3 · ownership.nature: (Continued from Footnote 2) The six member investment committee of OEP VII GP acts by majority vote, which majority must include Richard Cashin. Accordingly, Richard Cashin may be deemed to have voting and investment discretion, and beneficial ownership, of the reported securities. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.

Read SEC document
March 12, 2026 Filed Mar 30, 2026 23:32 UTC Amendment PurchaseCommon Stock 689,336 $9.73 $6,707,170.35
Disclosure

SEC source: 0001193125-26-132663 · ownership.xml · nonDerivative · entry 3

OEP VII GP, L.L.C. · CIK 0001817118 · 10% owner

OEP AHCO Investment Holdings, LLC · CIK 0001817112 · 10% owner

ONE EQUITY PARTNERS VII, L.P. · CIK 0001733523 · 10% owner

ONE EQUITY PARTNERS VII-A, L.P. · CIK 0001733525 · 10% owner

ONE EQUITY PARTNERS VII-B, L.P. · CIK 0001733528 · 10% owner

OEP VII Project A Co-Investment Partners, L.P. · CIK 0001817120 · 10% owner

OEP VII PROJECT A-I CO-INVESTMENT PARTNERS, L.P. · CIK 0001821208 · 10% owner

OEP VII General Partner, L.P. · CIK 0001817115 · 10% owner

CASHIN RICHARD M JR · CIK 0001172898 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See

Disclosed balance after: 15,864,871

F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.55 to $9.75, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These securities are held directly by OEP AHCO Investment Holdings, LLC ("Investor"). Investor is owned by One Equity Partners VII, L.P., a Cayman Islands exempted limited partnership ("OEP VII LP"), One Equity Partners VII-A, L.P., a Cayman Islands exempted limited partnership ("OEP VII-A LP"), One Equity Partners VII-B, L.P., a Delaware limited partnership ("OEP VII-B LP"), OEP VII Project A Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A LP") and OEP VII Project A-I Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A-I LP" and, together with OEP VII LP, OEP VII-A LP, OEP VII-B LP and OEP VII Project A LP, the "Parallel Funds"). The general partner of each of the Parallel Funds is OEP VII General Partner, L.P., a Cayman Islands exempted limited partnership ("OEP VII GP"), and the general partner of OEP VII GP is OEP VII GP, L.L.C., a Cayman Islands limited liability company ("OEP VII GP LLC").

F3 · ownership.nature: (Continued from Footnote 2) The six member investment committee of OEP VII GP acts by majority vote, which majority must include Richard Cashin. Accordingly, Richard Cashin may be deemed to have voting and investment discretion, and beneficial ownership, of the reported securities. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 01:11 UTC PurchaseCommon Stock 536,827 $9.73 $5,222,306.74
Disclosure

SEC source: 0001193125-26-104760 · ownership.xml · nonDerivative · entry 2

CASHIN RICHARD M JR · CIK 0001172898 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 15,175,535

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.64 to $9.75, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These securities are held directly by OEP AHCO Investment Holdings, VI LLC ("Investor"). Investor is owned by One Equity Partners VII, L.P., a Cayman Islands exempted limited partnership ("OEP VII LP"), One Equity Partners VII-A, L.P., a Cayman Islands exempted limited partnership ("OEP VII-A LP"), One Equity Partners VII-B, L.P., a Delaware limited partnership ("OEP VII-B LP"), OEP VII Project A Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A LP") and OEP VII Project A-I Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A-I LP" and, together with OEP VII LP, OEP VII-A LP, OEP VII-B LP and OEP VII Project A LP, the "Parallel Funds"). The general partner of each of the Parallel Funds is OEP VII General Partner, L.P., a Cayman Islands exempted limited partnership ("OEP VII GP"), and the general partner of OEP VII GP is OEP VII GP, L.L.C., a Cayman Islands limited liability company ("OEP VII GP LLC").

F3 · ownership.nature: (Continued from Footnote 2) The six member investment committee of OEP VII GP acts by majority vote, which majority must include Richard Cashin. Accordingly, Richard Cashin may be deemed to have voting and investment discretion, and beneficial ownership, of the reported securities. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.

Read SEC document
March 11, 2026 Filed Mar 30, 2026 23:32 UTC Amendment PurchaseCommon Stock 536,827 $9.73 $5,222,306.74
Disclosure

SEC source: 0001193125-26-132663 · ownership.xml · nonDerivative · entry 2

OEP VII GP, L.L.C. · CIK 0001817118 · 10% owner

OEP AHCO Investment Holdings, LLC · CIK 0001817112 · 10% owner

ONE EQUITY PARTNERS VII, L.P. · CIK 0001733523 · 10% owner

ONE EQUITY PARTNERS VII-A, L.P. · CIK 0001733525 · 10% owner

ONE EQUITY PARTNERS VII-B, L.P. · CIK 0001733528 · 10% owner

OEP VII Project A Co-Investment Partners, L.P. · CIK 0001817120 · 10% owner

OEP VII PROJECT A-I CO-INVESTMENT PARTNERS, L.P. · CIK 0001821208 · 10% owner

OEP VII General Partner, L.P. · CIK 0001817115 · 10% owner

CASHIN RICHARD M JR · CIK 0001172898 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See

Disclosed balance after: 15,175,535

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.64 to $9.75, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These securities are held directly by OEP AHCO Investment Holdings, LLC ("Investor"). Investor is owned by One Equity Partners VII, L.P., a Cayman Islands exempted limited partnership ("OEP VII LP"), One Equity Partners VII-A, L.P., a Cayman Islands exempted limited partnership ("OEP VII-A LP"), One Equity Partners VII-B, L.P., a Delaware limited partnership ("OEP VII-B LP"), OEP VII Project A Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A LP") and OEP VII Project A-I Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A-I LP" and, together with OEP VII LP, OEP VII-A LP, OEP VII-B LP and OEP VII Project A LP, the "Parallel Funds"). The general partner of each of the Parallel Funds is OEP VII General Partner, L.P., a Cayman Islands exempted limited partnership ("OEP VII GP"), and the general partner of OEP VII GP is OEP VII GP, L.L.C., a Cayman Islands limited liability company ("OEP VII GP LLC").

F3 · ownership.nature: (Continued from Footnote 2) The six member investment committee of OEP VII GP acts by majority vote, which majority must include Richard Cashin. Accordingly, Richard Cashin may be deemed to have voting and investment discretion, and beneficial ownership, of the reported securities. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.

Read SEC document
March 10, 2026 Filed Mar 13, 2026 01:11 UTC PurchaseCommon Stock 820,528 $9.73 $7,982,670.75
Disclosure

SEC source: 0001193125-26-104760 · ownership.xml · nonDerivative · entry 1

CASHIN RICHARD M JR · CIK 0001172898 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 14,638,708

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.58 to $9.95, inclusive. The reporting persons undertake to provide to AdaptHealth Corp., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These securities are held directly by OEP AHCO Investment Holdings, VI LLC ("Investor"). Investor is owned by One Equity Partners VII, L.P., a Cayman Islands exempted limited partnership ("OEP VII LP"), One Equity Partners VII-A, L.P., a Cayman Islands exempted limited partnership ("OEP VII-A LP"), One Equity Partners VII-B, L.P., a Delaware limited partnership ("OEP VII-B LP"), OEP VII Project A Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A LP") and OEP VII Project A-I Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A-I LP" and, together with OEP VII LP, OEP VII-A LP, OEP VII-B LP and OEP VII Project A LP, the "Parallel Funds"). The general partner of each of the Parallel Funds is OEP VII General Partner, L.P., a Cayman Islands exempted limited partnership ("OEP VII GP"), and the general partner of OEP VII GP is OEP VII GP, L.L.C., a Cayman Islands limited liability company ("OEP VII GP LLC").

F3 · ownership.nature: (Continued from Footnote 2) The six member investment committee of OEP VII GP acts by majority vote, which majority must include Richard Cashin. Accordingly, Richard Cashin may be deemed to have voting and investment discretion, and beneficial ownership, of the reported securities. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.

Read SEC document
March 10, 2026 Filed Mar 30, 2026 23:32 UTC Amendment PurchaseCommon Stock 820,528 $9.73 $7,982,670.75
Disclosure

SEC source: 0001193125-26-132663 · ownership.xml · nonDerivative · entry 1

OEP VII GP, L.L.C. · CIK 0001817118 · 10% owner

OEP AHCO Investment Holdings, LLC · CIK 0001817112 · 10% owner

ONE EQUITY PARTNERS VII, L.P. · CIK 0001733523 · 10% owner

ONE EQUITY PARTNERS VII-A, L.P. · CIK 0001733525 · 10% owner

ONE EQUITY PARTNERS VII-B, L.P. · CIK 0001733528 · 10% owner

OEP VII Project A Co-Investment Partners, L.P. · CIK 0001817120 · 10% owner

OEP VII PROJECT A-I CO-INVESTMENT PARTNERS, L.P. · CIK 0001821208 · 10% owner

OEP VII General Partner, L.P. · CIK 0001817115 · 10% owner

CASHIN RICHARD M JR · CIK 0001172898 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See

Disclosed balance after: 14,638,708

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.58 to $9.95, inclusive. The reporting persons undertake to provide to AdaptHealth Corp., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These securities are held directly by OEP AHCO Investment Holdings, LLC ("Investor"). Investor is owned by One Equity Partners VII, L.P., a Cayman Islands exempted limited partnership ("OEP VII LP"), One Equity Partners VII-A, L.P., a Cayman Islands exempted limited partnership ("OEP VII-A LP"), One Equity Partners VII-B, L.P., a Delaware limited partnership ("OEP VII-B LP"), OEP VII Project A Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A LP") and OEP VII Project A-I Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A-I LP" and, together with OEP VII LP, OEP VII-A LP, OEP VII-B LP and OEP VII Project A LP, the "Parallel Funds"). The general partner of each of the Parallel Funds is OEP VII General Partner, L.P., a Cayman Islands exempted limited partnership ("OEP VII GP"), and the general partner of OEP VII GP is OEP VII GP, L.L.C., a Cayman Islands limited liability company ("OEP VII GP LLC").

F3 · ownership.nature: (Continued from Footnote 2) The six member investment committee of OEP VII GP acts by majority vote, which majority must include Richard Cashin. Accordingly, Richard Cashin may be deemed to have voting and investment discretion, and beneficial ownership, of the reported securities. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.

Read SEC document
March 05, 2026 Filed Mar 10, 2026 01:14 UTC GiftCommon Stock 73,472 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-025412 · tm268335-1_4seq1.xml · nonDerivative · entry 2

Weaver Susan T · CIK 0001687804 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Irrevocable Trust

Disclosed balance after: 73,472

F1 · ownership.nature: On March 5, 2025, the reporting person transferred 73,472 shares of AdaptHealth Corp. common stock to the Susan T. Weaver 2025 Irrevocable Trust, of which the reporting person's spouse and son are the co-trustees and the reporting person's spouse and children are the beneficiaries.

Read SEC document
March 05, 2026 Filed Mar 10, 2026 01:14 UTC GiftCommon Stock 73,472 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-025412 · tm268335-1_4seq1.xml · nonDerivative · entry 1

Weaver Susan T · CIK 0001687804 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,346

Read SEC document
February 27, 2026 Filed Mar 3, 2026 23:41 UTC
WOLF DALE BDirector
PurchaseCommon Stock 8,000 $8.96 $71,680.00
Disclosure

SEC source: 0001104659-26-023001 · tm267918-1_4seq1.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,235

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.94 to $8.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) .

Read SEC document
February 26, 2026 Filed Feb 27, 2026 16:01 UTC
Rew Richard W. IICLO and General Counsel
PurchaseCommon Stock 5,000 $8.91 $44,550.00
Disclosure

SEC source: 0001104659-26-021535 · tm267540-1_4seq1.xml · nonDerivative · entry 1

Rew Richard W. II · CIK 0001433265 · CLO and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,097

Read SEC document
January 30, 2026 Filed Feb 4, 2026 01:20 UTC
McFadden Daniel EdwardChief Business Systems Officer
GrantCommon Stock 29,284 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-009923 · tm264996-4_4seq1.xml · nonDerivative · entry 1

McFadden Daniel Edward · CIK 0002074058 · Chief Business Systems Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,242

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
January 30, 2026 Filed Feb 4, 2026 01:23 UTC
Schuster III Russell E.Chief Commercial Officer
GrantCommon Stock 48,807 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-009928 · tm264996-7_4seq1.xml · nonDerivative · entry 1

Schuster III Russell E. · CIK 0002048040 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,813

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
January 30, 2026 Filed Feb 3, 2026 20:22 UTC
Barnhart Toby ScottChief Operating Officer
GrantCommon Stock 68,330 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-009927 · tm264996-6_4seq1.xml · nonDerivative · entry 1

Barnhart Toby Scott · CIK 0002037824 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,654

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
January 30, 2026 Filed Feb 3, 2026 20:24 UTC
Rew Richard W. IICLO and General Counsel
GrantCommon Stock 53,688 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-009929 · tm264996-8_4seq1.xml · nonDerivative · entry 1

Rew Richard W. II · CIK 0001433265 · CLO and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,097

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

F1 · price: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
January 30, 2026 Filed Feb 4, 2026 01:21 UTC
Prast Albert A.Chief Technology Officer
GrantCommon Stock 63,449 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-009925 · tm264996-5_4seq1.xml · nonDerivative · entry 1

Prast Albert A. · CIK 0001628262 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 442,907

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
January 30, 2026 Filed Feb 4, 2026 01:18 UTC
Foster SuzanneDirector · Chief Executive Officer
GrantCommon Stock 329,449 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-009921 · tm264996-3_4seq1.xml · nonDerivative · entry 1

Foster Suzanne · CIK 0001766653 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 924,050

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
January 30, 2026 Filed Feb 4, 2026 01:15 UTC
Archbold Christine E.Chief Accounting Officer
GrantCommon Stock 32,213 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-009920 · tm264996-2_4seq1.xml · nonDerivative · entry 1

Archbold Christine E. · CIK 0001802571 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,198

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
January 30, 2026 Filed Feb 4, 2026 01:13 UTC
Clemens Jason AChief Financial Officer
GrantCommon Stock 126,899 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-009919 · tm264996-1_4seq1.xml · nonDerivative · entry 1

Clemens Jason A · CIK 0001820867 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 673,481

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:22 UTC GrantCommon Stock 11,776 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-003345 · tm262967-1_4seq1.xml · nonDerivative · entry 1

BELINFANTI GREGORY · CIK 0001471787 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,270

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 21:23 UTC GrantCommon Stock 13,740 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-003351 · tm262967-2_4seq1.xml · nonDerivative · entry 1

Lundberg Theodore B. · CIK 0001628260 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 873,496

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
December 04, 2025 Filed Dec 5, 2025 22:35 UTC SaleCommon Stock 5,000 $9.43 $47,150.00
Disclosure

SEC source: 0001104659-25-118948 · tm2532878-1_4seq1.xml · nonDerivative · entry 1

Williams David Solomon III · CIK 0001820444 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,045

Read SEC document
August 22, 2025 Filed Aug 22, 2025 23:33 UTC SaleCommon Stock 8,200 $9.73 $79,786.00
Disclosure

SEC source: 0001104659-25-081982 · tm2524230-1_4seq1.xml · nonDerivative · entry 1

Williams David Solomon III · CIK 0001820444 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,045

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.60 to $9.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)

Read SEC document
June 26, 2025 Filed Jun 30, 2025 23:32 UTC GrantCommon Stock 21,346 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-064281 · tm2519424-3_4seq1.xml · nonDerivative · entry 1

Williams David Solomon III · CIK 0001820444 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,245

Read SEC document
June 26, 2025 Filed Jun 30, 2025 23:34 UTC GrantCommon Stock 21,346 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-064284 · tm2519424-6_4seq1.xml · nonDerivative · entry 1

Weaver Susan T · CIK 0001687804 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,818

Read SEC document
June 26, 2025 Filed Jun 30, 2025 23:35 UTC GrantCommon Stock 21,346 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-064286 · tm2519424-7_4seq1.xml · nonDerivative · entry 1

Connors Terence J · CIK 0001689279 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,263

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.